Thailand · Delayed Price · Currency is THB AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of THB 11.83 trillion. The enterprise value is 13.88 trillion.
| Market Cap | 11.83T |
| Enterprise Value | 13.88T |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | Apr 16, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 75.42% |
| Float | 1.77B |
Valuation Ratios
The trailing PE ratio is 100.85 and the forward PE ratio is 13.73.
| PE Ratio | 100.85 |
| Forward PE | 13.73 |
| PS Ratio | 5.77 |
| PB Ratio | -112.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 118.29 |
| EV / Sales | 6.82 |
| EV / EBITDA | 14.10 |
| EV / EBIT | 19.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.25 |
| Debt / FCF | n/a |
| Interest Coverage | 7.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 22.24% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 35.97M |
| Profits Per Employee | 2.06M |
| Employee Count | 57,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AbbVie has paid 76.17 billion in taxes.
| Income Tax | 76.17B |
| Effective Tax Rate | 39.06% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 43.25 |
| Average Volume (20 Days) | 120,353 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.02 |
Income Statement
In the last 12 months, AbbVie had revenue of THB 2.05 trillion and earned 117.33 billion in profits. Earnings per share was 66.25.
| Revenue | 2.05T |
| Gross Profit | 1.48T |
| Operating Income | 713.68B |
| Pretax Income | 195.00B |
| Net Income | 117.33B |
| EBITDA | 979.17B |
| EBIT | 713.68B |
| Earnings Per Share (EPS) | 66.25 |
Balance Sheet
The company has 171.57 billion in cash and 2.23 trillion in debt, with a net cash position of -2,060.73 billion.
| Cash & Cash Equivalents | 171.57B |
| Total Debt | 2.23T |
| Net Cash | -2,060.73B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -105.35B |
| Book Value Per Share | -60.37 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 266.51B |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 72.03%, with operating and profit margins of 34.81% and 5.79%.
| Gross Margin | 72.03% |
| Operating Margin | 34.81% |
| Pretax Margin | 9.51% |
| Profit Margin | 5.79% |
| EBITDA Margin | 47.76% |
| EBIT Margin | 34.81% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.96% |
| Earnings Yield | 0.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |